Elevated insulin, insulin-like growth factor 1 (IGF-1), and estrogen levels, alongside reduced IGF-binding proteins (IGFBPs) and SHBG, are associated with increased BC risk, recurrence, and mortality [84,85,86,87,88,89]. This evidence concerns the gene SHBG and breast cancer.